The recommended starting regimen (administered 2x or 3x weekly) is
Patients <12 years may require more frequent or higher dose
In AFSTYLA clinical trials, median doses were:
Note: For healthcare professional use only. Use of this tool is not a substitute for the clinical expertise of a licensed medical professional.